Metasurface Biosensor Resonant Scattering for Rapid Point-of-Care Diagnostics
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting biomarkers such as nucleic acids, proteins, and pathogens are either slow and sensitive or rapid and imprecise, and lack the ability to be used at the point-of-care, failing to meet the World Health Organization's ASSURED guidelines for affordability, sensitivity, and user-friendliness.
Innovation Solution
The development of high-quality-factor nanostructured dielectric substrates, known as metasurfaces, which use resonant scattering intensities to detect DNA, viral-RNA, antibodies, and whole pathogens without amplification, enabling rapid and quantitative measurements using a laser or light-emitting diode for optical readout, and are adaptable for various infectious agents and diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods like RT-PCR and ELISA are used, then sensitivity is improved, but testing time increases significantly
Solution Approach 1:
The patent replaces complex mechanical and chemical amplification systems (PCR cycling, ELISA incubation steps) with a photonic resonance detection system. The metasurface resonators directly transduce biomarker binding events into optical signal changes, eliminating the need for thermal cycling, enzymatic amplification, and multi-step washing procedures, thereby achieving rapid detection without sacrificing sensitivity
Solution Approach 2:
The patent changes the detection parameter from measuring amplified product concentration (after hours of processing) to measuring resonance frequency shifts in real-time. By monitoring the resonant frequency of metasurface structures that change when biomarkers bind, the system achieves both rapid response and high sensitivity simultaneously
2Productivity
If rapid detection methods like lateral flow assays are used, then testing time is reduced, but measurement precision deteriorates
Solution Approach 1:
The patent employs resonant oscillation of metasurface structures as the detection mechanism. When biomarkers bind to the metasurface, they alter the mass and mechanical properties of the resonator, causing measurable frequency shifts. This vibration-based detection provides both rapid response (real-time monitoring) and high precision (quantitative frequency measurements)
Solution Approach 2:
The patent uses periodic excitation of the metasurface resonators to generate clear resonance signals. By driving the structures at their resonant frequencies and measuring the response, the system achieves rapid detection with high signal-to-noise ratio, overcoming the precision limitations of conventional rapid tests
3Measurement precision
If complex amplification and labeling procedures are implemented, then detection sensitivity is improved, but device complexity increases
Solution Approach 1:
The patent extracts and eliminates the complex amplification and labeling components from the detection system. Instead of requiring PCR reagents, enzymes, or fluorescent labels, the system uses the intrinsic optical resonance properties of the metasurface structures themselves to detect biomarkers directly, simplifying the assay while maintaining sensitivity
Solution Approach 2:
The metasurface resonators serve as both the sensing element and the signal generation mechanism. The structures self-generate strong optical fields through resonance, eliminating the need for external amplification systems or labeling reagents, thereby reducing device complexity while maintaining detection sensitivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides near-instantaneous results, low detection limits, and is cost-effective, scalable, and user-friendly, allowing for point-of-care diagnostics with sensitivity comparable to RT-PCR and ELISA assays, and multiplexing capabilities, reducing the need for reagents and training.
Implementation Method 1
high-quality-factor (''high-Q'') nanostructured dielectric substrates, known as metasurfaces, that generate resonant scattering intensities with high sensitivity that is proportional to adsorbed biomarker load
Implementation Method 2
The metasurfaces are then illuminated with a laser or light-emitting diode, and the optical readout of the transmitted or reflected incident light provides quantitative, sensitive, and real-time monitoring of nucleic acids, antibody, or whole-pathogen targets
Data Source
AI summary
Optical sensing of biological targets is provided using a metasurface having guided mode resonances with electric field profiles that extend out from the metasurface. Surface functionalization of such metasurfaces can be used to provide sensing for biological targets, such as nucleic acids, proteins, small molecules, extracellular vesicles, and whole cells. Binding of the target to the surface functionalization can affect the resonance wavelength of the guided mode resonances, thereby providing a sensitive assay for the biological targets.